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 The nitrogen heterocyclic organic compounds 1,4 dioxide pyrazine and quinoxaline 
derivatives have been widely studied due to their potential use as synthetic drugs. The 
thermochemical study of three N,N´-dioxides: 2,3,5-trimethylpyrazine-1,4-dioxide, 
tetramethylpyrazine-1,4-dioxide and 6-chloro-2,3-dimethilquinoxaline 1,4-dioxide has been 
recently developed in order to establish relationships among the energetical, structural and 
reactivity properties [4,5]. Several studies have reported their pharmacological activity, 
particularly as antimicrobial agents [1,2,3]. It has also been established a relation between 
energetical and structural properties and biological activity, once these compounds present N – 
oxide bonds, increasing their oxidative capacity. 
 The present work reports the study of antimicrobial activity for those compounds against 
the bacteria Geobacillus stearothermophylus, Staphylococcus aureus, Streptococcus agalactiae, 
Escherichia coli and also against the yeasts Saccharomyces cerevisiae PYCC 4072, Candida 
albicans PYCC3436
T
, Candida tropicalis PYCC, Issatchenka Orientalis PYCC. The 
determination of the minimal inhibitory concentration (MIC), points to an antimicrobial activity 
and the preliminary results indicate that these compounds may be potential candidates as 
antimicrobial drugs with clinical, agriculture or food industries applications. 
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